首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1136936

兒童用抗生素市場:感染疾病，各給藥途徑，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年08月29日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場動態

全球兒科抗生素市場的主要參與者正專注於採用產品批准等增長戰略，預計這將在預測期內推動市場增長。

本調查的主要特徵

本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球兒童用抗生素市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球兒童用抗生素市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球兒童用抗生素市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球兒童用抗生素市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

熱圖分析
市場佔有率分析
- Johnson & Johnson
- Astellas Pharma, Inc.
- Pfizer Inc.,
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- Abbott
- DAIICHI SANKYO COMPANY, LIMITED
- Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc.
- Aurobindo Pharma USA
- GlaxoSmithKline Plc.,
- Hikma Pharmaceuticals PLC
- Cipla Inc.
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd.

第10章章節

調查手法的介紹
關於出版社

簡介目錄

Product Code: CMI5190

Antibiotics are used to treat or prevent some types of bacterial infection. Antibiotics work by killing bacteria or preventing them from reproducing and spreading. Antibiotics are the most commonly prescribed drugs in children and have the potential to save the lives of patients with severe bacterial infections such as Non-Specific Upper Respiratory Tract Infections, Urinary Tract Infections etc. They are taken orally and come in the form of tablets, liquid suspension, and capsules. Antibiotics are also administered through the intravenous route. Antibiotics are available in the form of ointments, creams, lotions, etc. for topical administration.

Market Dynamics

Key players operating in the global pediatric antibiotics market are focusing on adoption of growth strategies such as product approval, which is expected to drive market growth during the forecast period. For instance, in January 2020, Merck a leading global biopharmaceutical company known as MSD outside of the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) had approved a New Drug Application (NDA) for DIFICID (fidaxomicin) for oral suspension, and a supplemental New Drug Application (sNDA) for DIFICID tablets for the treatment of Clostridioides (formerly Clostridium) difficile-associated diarrhea (CDAD) in children aged six months and older. Moreover, increasing demand of pediatric antibiotics is expected to propel market growth over the forecast period. For instance, in 2021, United Nations International Children's Emergency Fund (UNICEF) delivered 31.6 million antibiotic treatments to children under one year of age in 54 countries.

Key features of the study:

This report provides in-depth analysis of the global pediatric antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pediatric antibiotics market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Inc, Pfizer Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Abbott., DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy's Laboratories Ltd, Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA, GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Cipla Inc., Glenmark Pharmaceuticals, and Torrent Pharmaceuticals Ltd. Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pediatric antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric antibiotics market.

Detailed Segmentation:

Global Pediatric antibiotics Market, By Infection :
- Acute Sinusitis
- Acute Otitis Media
- Non-Specific Upper Respiratory Tract Infections
- Urinary Tract Infections
- Others
Global Pediatric antibiotics Market, By Route of Administration :
- Oral
- Topical
- Intravenous
- Others
Global Pediatric antibiotics Market, By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
Global Pediatric antibiotics Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Johnson & Johnson.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Astellas Pharma, Inc,
- Pfizer Inc
- Novartis AG
- Bayer AG
- Bristol-Myers Squibb Company
- Abbott
- DAIICHI SANKYO COMPANY, LIMITED
- Dr. Reddy's Laboratories Ltd
- Teva Pharmaceuticals USA, Inc
- Aurobindo Pharma USA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals PLC
- Cipla Inc
- Glenmark Pharmaceuticals
- Torrent Pharmaceuticals Ltd., etc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Infection
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Distribution Channels
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
Key Developments
Epidemiology
PEST Analysis
Collaboration and Acquisition
Porters Analysis
Treatment Algorithm

4. Global Pediatric Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
Impact on Demand and Supply
COVID-19 Impact Assessments

5. Global Pediatric Antibiotics Market, By Infection, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Acute Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Acute Otitis Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Non-Specific Upper Respiratory Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Pediatric Antibiotics Market, By Route Of Administration, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Pediatric Antibiotics Market, By Distribution Channel, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
E-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Pediatric Antibiotics Market, By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Astellas Pharma, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Pfizer Inc.,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Abbott
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- DAIICHI SANKYO COMPANY, LIMITED
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Reddy's Laboratories Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Teva Pharmaceuticals USA, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Aurobindo Pharma USA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- GlaxoSmithKline Plc.,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Cipla Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Glenmark Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Torrent Pharmaceuticals Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

兒童用醫藥品的中國市場

兒科藥物市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型、給藥途徑、最終用戶、地區、競爭細分

兒科安寧療護藥物市場：依藥物類別、給藥途徑、通路、地區：規模、份額、前景、機會分析，2023-2030

FAQ

兒童用抗生素市場:感染疾病，各給藥途徑，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市場動態

本調查的主要特徵

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態，法規，及趨勢的分析

第4章兒童用抗生素的全球市場-冠狀病毒(COVID-19)疫情的影響

第5章兒童用抗生素的全球市場，感染疾病，2017-2030年

第6章兒童用抗生素的全球市場(各給藥途徑):2017年～2030年

第7章兒童用抗生素的全球市場(各流通管道):2017年～2030年

第8章兒童用抗生素的全球市場:各地區，2017-2030年

第9章競爭情形

第10章章節

Market Dynamics

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pediatric Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pediatric Antibiotics Market, By Infection, 2017-2030, (US$ Mn)

6. Global Pediatric Antibiotics Market, By Route Of Administration, 2017-2030, (US$ Mn)

7. Global Pediatric Antibiotics Market, By Distribution Channel, 2017-2030, (US$ Mn)

8. Global Pediatric Antibiotics Market, By Region, 2017-2030, (US$ Mn)

9. Competitive Landscape

10. Section

兒童用抗生素市場:感染疾病，各給藥途徑，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

Pediatric Antibiotics Market, By Infection, By Route Of Administration, By Distribution Channel and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

市場動態

本調查的主要特徵

目錄

第1章 調查目的與前提條件

第2章 市場展望

第3章 市場動態，法規，及趨勢的分析

第4章 兒童用抗生素的全球市場-冠狀病毒(COVID-19)疫情的影響

第5章 兒童用抗生素的全球市場，感染疾病，2017-2030年

第6章 兒童用抗生素的全球市場(各給藥途徑):2017年～2030年

第7章 兒童用抗生素的全球市場(各流通管道):2017年～2030年

第8章 兒童用抗生素的全球市場:各地區，2017-2030年

第9章 競爭情形

第10章 章節

Market Dynamics

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pediatric Antibiotics Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pediatric Antibiotics Market, By Infection, 2017-2030, (US$ Mn)

6. Global Pediatric Antibiotics Market, By Route Of Administration, 2017-2030, (US$ Mn)

7. Global Pediatric Antibiotics Market, By Distribution Channel, 2017-2030, (US$ Mn)

8. Global Pediatric Antibiotics Market, By Region, 2017-2030, (US$ Mn)

9. Competitive Landscape

10. Section

第1章調查目的與前提條件

第2章市場展望

第3章市場動態，法規，及趨勢的分析

第4章兒童用抗生素的全球市場-冠狀病毒(COVID-19)疫情的影響

第5章兒童用抗生素的全球市場，感染疾病，2017-2030年

第6章兒童用抗生素的全球市場(各給藥途徑):2017年～2030年

第7章兒童用抗生素的全球市場(各流通管道):2017年～2030年

第8章兒童用抗生素的全球市場:各地區，2017-2030年

第9章競爭情形

第10章章節